Reversal of Pulmonary Fibrosis: Human Umbilical Mesenchymal Stem Cells from Wharton’s Jelly versus Human-Adipose-Derived Mesenchymal Stem Cells
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Pulmonary fibrosis (PF) is a progressive, non-reversible illness with various etiologies. Currently, effective treatments for fibrotic lungs are still lacking. Here, we compared the effectiveness of transplantation of human mesenchymal stem cells from umbilical cord Wharton’s jelly (HUMSCs) versus those from adipose tissue (ADMSCs) in reversing pulmonary fibrosis in rats. Bleomycin 5 mg was intratracheally injected to establish a severe, stable, single left lung animal model with PF. On Day 21 post-BLM administration, one single transplantation of 2.5 × 107 HUMSCs or ADMSCs was performed. Lung function examination of Injury and Injury+ADMSCs rats displayed significantly decreased blood oxygen saturation and increased respiratory rates, while Injury+HUMSCs rats showed statistical amelioration in blood oxygen saturation and significant alleviation in respiratory rates. Reduced cell number in the bronchoalveolar lavage and lower myofibroblast activation appeared in the rats transplanted with either ADMSCs or HUMSCS than that in the Injury group. However, ADMSC transplantation stimulated more adipogenesis. Furthermore, matrix-metallopeptidase-9 over-expression for collagen degradation, and the elevation of Toll-like receptor-4 expression for alveolar regeneration were observed only in the Injury+HUMSCs. In comparison with the transplantation of ADMSCs, transplantation of HUMSCs exhibited a much more effective therapeutic effect on PF, with significantly better results in alveolar volume and lung function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several phase 1 trials, including AETHER, demonstrated stem cells were safe and feasible to use in IPF [160–163].”
From Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF) (2024) · cites this paper as [161]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Integrating mechanisms of pulmonary fibrosis
Wynn, T. A. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110551 · Cited by 1,274
Obesity and cardiovascular disease: revisiting an old relationship
Koliaki, C., Liatis, S., & Kokkinos, A. (2019) · Metabolism · doi:10.1016/j.metabol.2018.10.011 · Cited by 719
Idiopathic pulmonary fibrosis: pathogenesis and management
Sgalla, G., Iovene, B., Calvello, M., Ori, M., Varone, F., & Richeldi, L. (2018) · Respiratory Research · doi:10.1186/s12931-018-0730-2 · Cited by 573
Mortality from Pulmonary Fibrosis Increased in the United States from 1992 to 2003
Olson, A. L., Swigris, J. J., Lezotte, D. C., Norris, J. M., Wilson, C. G., & Brown, K. K. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-044oc · Cited by 435
Human Umbilical Cord Mesenchymal Stem Cells Reduce Fibrosis of Bleomycin-Induced Lung Injury
Moodley, Y., Atienza, D., Manuelpillai, U., Samuel, C. S., Tchongue, J., Ilancheran, S., Boyd, R., & Trounson, A. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080629 · Cited by 356
Liang, J., Zhang, Y., Xie, T., Liu, N., Chen, H., Geng, Y., Kurkciyan, A., Mena, J. M., Stripp, B. R., Jiang, D., et al. (2016) · Nature Medicine · doi:10.1038/nm.4192 · Cited by 287 · cited 1×
“It is known that TLR-4 activation plays a critical part in regenerating and reconstituting alveolar epithelial cells [31].”
BackgroundTzouvelekis, A., Paspaliaris, V., Koliakos, G., Ntolios, P., Bouros, E., Oikonomou, A., Zissimopoulos, A., Boussios, N., Dardzinski, B., Gritzalis, D., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-171 · Cited by 255 · cited 1×
“Several clinical trials have also confirmed that the transplantation of autologous ADMSCs did not significantly improve the lung function of idiopathic pulmonary fibrosis patients [35,36].”
BackgroundConfalonieri, P., Volpe, M. C., Jacob, J., Maiocchi, S., Salton, F., Ruaro, B., Confalonieri, M., & Braga, L. (2022) · Cells · doi:10.3390/cells11132095 · Cited by 164
Cited by
Idiopathic pulmonary fibrosis microenvironment: Novel mechanisms and research directions
Gao, F., Pan, L., Liu, W., Chen, J., Wang, Y., Li, Y., Liu, Y., Hua, Y., Li, R., Zhang, T., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114653 · Cited by 37
Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF)
Aribindi, K., Liu, G. Y., & Albertson, T. E. (2024) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2024.2396121 · Cited by 17
Tsuji, S., Mukai, T., Tsuchiya, H., Iwatani, C., Nakamura, A., Nagamura‐Inoue, T., & Murakami, T. (2023) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12540 · Cited by 7
Nakamura, Y., Niho, S., & Shimizu, Y. (2024) · Cells · doi:10.3390/cells13110893 · Cited by 9
“…the involvement of matrix metalloproteinases (MMPs; with varying increases and decreases, depending on the literature and subtype) [61,69,73,81], reduced inflammatory cytokines (tumor necrosis factor alpha [TNF-α ], interleukin [IL]-1 α , IL-2, IL-1 β , IL-4, and interferon gamma)…”
BackgroundMesenchymal stromal cells: an update
Lee, O. J., & Keating, A. (2025) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000887 · Cited by 6
Metadata
- Authors
- Chu, K.-A., Yeh, C.-C., Hsu, C.-H., Hsu, C.-W., Kuo, F.-H., Tsai, P.-J., & Fu, Y.-S.
- Affiliations
- National Sun Yat-sen University (TW)
- National Yang Ming Chiao Tung University (TW)
- Kaohsiung Veterans General Hospital (TW)
- Corresponding author
- Tsai, Pei-Jiun
- Fu, Yu-Show
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2023-04-08
- Volume
- 24
- Issue
- 8
- Pages
- 6948
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC10139084
- OpenAlex
- W4362733038
- Cited by
- 13
- References
- 47
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 3 · 2023: 1
- FWCI
- 2.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Yang Ming Chiao Tung University (MOST111-2321-B-A49-007, VGHUST111-G3-1-2, VGHUST112-G3-1-2, VGHKS111-135, KSVGH112-070, VGHUST111-G3-1-1, VGHUST112-G3-1-1)
- Veterans General Hospitals and University System of Taiwan Joint Research Program (MOST111-2321-B-A49-007, VGHUST111-G3-1-2, VGHUST112-G3-1-2, VGHKS111-135, KSVGH112-070, VGHUST111-G3-1-1, VGHUST112-G3-1-1)
- Kaohsiung Veterans General Hospital (MOST111-2321-B-A49-007, VGHUST111-G3-1-2, VGHUST112-G3-1-2, VGHKS111-135, KSVGH112-070, VGHUST111-G3-1-1, VGHUST112-G3-1-1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- pulmonary fibrosis, mesenchymal stem cells, Wharton's jelly, human umbilical cord mesenchymal stem cells, adipose-derived stem cells, stem cell transplantation, bleomycin-induced lung injury, myofibroblast activation, adipogenesis, MMP-9, TLR4, alveolar regeneration, lung function, rat model
- MeSH terms
- Animals, Humans, Pulmonary Fibrosis, Transplantation, Heterologous, Umbilical Cord, Mesenchymal Stem Cell Transplantation, Rats, Mesenchymal Stem Cells, Wharton Jelly
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reversal of Pulmonary Fibrosis: Human Umbilical Mesenchymal Stem Cells from Wharton’s Jelly versus Human-Adipose-Derived Mesenchymal Stem Cells. https://app.cochat.ai/papers/10.3390/ijms24086948
- The paper
- Chu, K.-A., Yeh, C.-C., Hsu, C.-H., Hsu, C.-W., Kuo, F.-H., Tsai, P.-J., & Fu, Y.-S. (2023). Reversal of Pulmonary Fibrosis: Human Umbilical Mesenchymal Stem Cells from Wharton’s Jelly versus Human-Adipose-Derived Mesenchymal Stem Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24086948
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.